Correlation Between Krebs Biochemicals and Gujarat Alkalies

Can any of the company-specific risk be diversified away by investing in both Krebs Biochemicals and Gujarat Alkalies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Krebs Biochemicals and Gujarat Alkalies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Krebs Biochemicals and and Gujarat Alkalies and, you can compare the effects of market volatilities on Krebs Biochemicals and Gujarat Alkalies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Krebs Biochemicals with a short position of Gujarat Alkalies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Krebs Biochemicals and Gujarat Alkalies.

Diversification Opportunities for Krebs Biochemicals and Gujarat Alkalies

-0.47

Correlation Coefficient

Krebs Biochemicals  Gujarat Alkalies

Very good diversification

The 3 months correlation between Krebs and Gujarat is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Krebs Biochemicals and and Gujarat Alkalies and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gujarat Alkalies and Krebs Biochemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Krebs Biochemicals and are associated (or correlated) with Gujarat Alkalies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gujarat Alkalies has no effect on the direction of Krebs Biochemicals i.e., Krebs Biochemicals and Gujarat Alkalies go up and down completely randomly.

Pair Corralation between Krebs Biochemicals and Gujarat Alkalies

Assuming the 90 days trading horizon Krebs Biochemicals and is expected to under-perform the Gujarat Alkalies. In addition to that, Krebs Biochemicals is 1.89 times more volatile than Gujarat Alkalies and. It trades about -0.16 of its total potential returns per unit of risk. Gujarat Alkalies and is currently generating about -0.25 per unit of volatility. If you would invest  80,885  in Gujarat Alkalies and on October 8, 2024 and sell it today you would lose (5,910) from holding Gujarat Alkalies and or give up 7.31% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Krebs Biochemicals and  vs.  Gujarat Alkalies and

Krebs Biochemicals and

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Krebs Biochemicals and are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak fundamental drivers, Krebs Biochemicals demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Gujarat Alkalies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Gujarat Alkalies and has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Krebs Biochemicals and Gujarat Alkalies

The main advantage of trading using opposite Krebs Biochemicals and Gujarat Alkalies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Krebs Biochemicals position performs unexpectedly, Gujarat Alkalies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gujarat Alkalies will offset losses from the drop in Gujarat Alkalies' long position.

The idea behind Krebs Biochemicals and and Gujarat Alkalies and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.